ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE- orphenadrine citrate, aspirin and caffeine tablet

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

ORPHENADRINE CITRATE (UNII: X0A40N8I4S) (ORPHENADRINE - UNII:AL805O9OG9), ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E), CAFFEINE (UNII: 3G6A5W338E) (CAFFEINE - UNII:3G6A5W338E)

から入手可能:

Atland Pharmaceuticals, LLC

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

Orphenadrine Citrate, Aspirin and Caffeine 25 mg/ 385 mg/ 30 mg Tablets are indicated in: - Symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - The orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. The mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. Orphenadrine Citrate, Aspirin and Caffeine Tablets do not directly relax tense muscles in man. Because of the mild anticholinergic effect of orphenadrine, Orphenadrine Citrate, Aspirin and Caffeine Tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. Orphenadrine Citrate, Aspirin and Caffeine Tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. The drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

製品概要:

Orphenadrine Citrate, Aspirin, and Caffeine Tablets (Orphenadrine Citrate 25 mg, Aspirin 385 mg, and Caffeine 30 mg): Two-layered, white/green round flat faced beveled edge tablet debossed “OAC” over “472” on the white side and plain on the green side. They are available in bottles of 60 tablets (NDC 71993-304-60). Store below 30°C (86°F) Rx Only Manufactured for: ATLAND Pharmaceuticals, LLC Sylacauga, AL 35150 500534-01 Rev. 08/2021

認証ステータス:

Abbreviated New Drug Application

製品の特徴

ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE - ORPHENADRINE CITRATE,
ASPIRIN AND CAFFEINE TABLET
ATLAND PHARMACEUTICALS, LLC
----------
ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE TABLETS 25 MG/ 385 MG/ 30
MG
DESCRIPTION
Each Orphenadrine Citrate, Aspirin and Caffeine Tablet, for oral
administration contains
Orphenadrine Citrate 25 mg, Aspirin 385 mg and Caffeine 30 mg.
In addition, each tablet contains the following inactive ingredients:
anhydrous lactose,
colloidal silicon dioxide, D&C yellow #10, FD&C blue #1, zinc
stearate, povidone,
pregelatinized starch, and stearic acid.
Orphenadrine citrate is (2-dimethylaminoethyl 2-methylbenzhydryl ether
citrate). It is a
white, practically odorless, crystalline powder, having a bitter
taste. It is sparingly soluble
in water; slightly soluble in alcohol. It has the following structural
formula:
Aspirin, salicylic acid acetate, is a non-opiate analgesic,
anti-inflammatory and antipyretic
agent It occurs as a white, crystalline tabular or needle-like powder
and is odorless or
has a faint odor. It is sparingly soluble in water, freely soluble in
alcohol and chloroform.
It has the following structural formula:
Caffeine is a central nervous system stimulant which occurs as a white
powder or white
glistening needles, usually matted together. It is sparingly soluble
in alcohol, and freely
soluble in chloroform. The chemical name for caffeine is,
1,3,7-Trimethylxanthine. It has
the following structural formula:
CLINICAL PHARMACOLOGY
Orphenadrine citrate is a centrally acting (brain stem) compound which
in animals
selectively blocks facilitatory functions of the reticular formation.
Orphenadrine does not
produce myoneural block, nor does it affect crossed extensor reflexes.
Orphenadrine
prevents nicotine-induced convulsions but not those produced by
strychnine.
Chronic administration of Orphenadrine Citrate, Aspirin and Caffeine
to dogs and rats
has revealed no drug-related toxicity. No blood or urine changes were
observed, nor
were there any macroscopic or microscopic pathological